InvestorsHub Logo
Followers 58
Posts 3961
Boards Moderated 0
Alias Born 04/23/2013

Re: dukesking post# 406644

Saturday, 04/01/2023 9:28:54 AM

Saturday, April 01, 2023 9:28:54 AM

Post# of 426486
We all bitched and moaned when the FDA moved the goal posts regarding the ANCHOR SPA, after the results of AIM-HIGH, HPS2-THRIVE, and the ACCORD-LIPID trials all showed significant TG reduction without outcome benefits.. We even formed the EPADI and filed a Citizens Petition to push back.

Ten years later, it turns out that the FDA was right. TG's are not a surrogate for CVD risk reduction and they will never accept that marker as such. However, it remains an important indicator that can't be ignored. That's why TG's are on the label.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News